The Next-Generation Food Allergy Drug Development Summit returns IN PERSON this December in Boston
Revolutionizing Food Allergy Products to Accelerate Curative Therapies to Market
The food allergy field is continuing to explode, as companies continue to bombard the headlines with new IND approvals and clinical read outs, with the race to market for the next food allergy therapeutic well and truly on.
The 2nd hotly anticipated Next Generation Food Allergy Drug Development Summit arrives in Boston this December, as the only industry focused meeting dedicated to unveiling the complexities of food allergies with novel oral immunotherapies, antibody-based therapeutics and microbiome-based approaches to accelerate ground-breaking treatments for the ever-increasing unmet medical need.
Unite in-person for the first time with your dedicated community of food allergy experts to supercharge your knowledge on the fundamental mechanisms of peanut, milk, egg, shellfish allergies and more, unravel the complex regulatory landscape, identify and validate novel clinical biomarkers to aid patient selection and explore novel routes of administration to innovate long-lasting next generation treatments.